G1 Therapeutics Added to Nasdaq Biotechnology Index
RESEARCH TRIANGLE PARK, N.C., Dec. 18, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq:NBI), effective prior …